Pfizer and Bristol Myers Squibb's blood thinner apixaban beat aspirin in a study that may open the door to a multi-billion dollar-a-year market to prevent clots. Meanwhile, rival drug Xarelto made by ...
(Reuters) - Once again, litigation over injuries allegedly caused by the blood thinner Xarelto- made by Bayer and Johnson & Johnson's Janssen - showed some of the biggest growth this month, followed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback